E3 Structure and Content of Clinical Study Reports - Questions and Answers (R1)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 29, 2013
April 29, 2020
5b7e3d17-9b0a-44df-bfcf-df3fae8991ae
Related Documents
S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals
Guidance DocumentDecember 16, 2009Center for Drug Evaluation and Research
Q11 Development and Manufacture of Drug Substances
Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research
Q8, Q9, and Q10 Questions and Answers
Guidance DocumentNovember 17, 2011Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox